STUDY ON SAFETY AND EFFECTIVENESS OF ORAL TOFACITINIB IN PATIENTS WITH REFRACTORY MODERATE TO SEVERE ATOPIC DERMATITIS. Int. Res. J. Pharm. 2018, 9 (8), 125-128. https://doi.org/10.56802/gzfvmr94.